SEMAX 10mg

$140.00

A synthetic nootropic heptapeptide derived from the fragmentation of ACTH (4-10).

It stimulates BDNF and NGF—key trophic factors for neuronal plasticity.

It has been investigated in the contexts of cognition, post-ischemic recovery, and attention disorders.

Originally developed in Russia, it is widely used in neurological research.

A synthetic nootropic heptapeptide derived from the fragmentation of ACTH (4-10).

It stimulates BDNF and NGF—key trophic factors for neuronal plasticity.

It has been investigated in the contexts of cognition, post-ischemic recovery, and attention disorders.

Originally developed in Russia, it is widely used in neurological research.

Product Details

In cognitive research, Semax is investigated for its influence on dopaminergic and serotonergic systems. Researchers study how the peptide modulates these neurotransmitter pathways in relation to attention, memory consolidation, and stress resilience, examining its effects without the corticotropic activity of the parent ACTH sequence.

02

03

Semax is a focus for researchers studying neuroplasticity and neuroprotection. Research suggests it upregulates brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF), proteins central to neuronal survival and synaptic plasticity. Studies use Semax to examine how elevated neurotrophic signaling influences hippocampal and cortical models of learning and neural adaptation.

01

Neurotrophic Factor Expression
Neurotransmitter Modulation & Cognition
Neuroprotection & Cellular Stress

Recent studies have utilized Semax to investigate neuronal protection under stress conditions. By examining its effects on oxidative stress markers and neuronal survival pathways, researchers explore the peptide’s role in models of ischemic and neurodegenerative stress.

Supplied as a purified, lyophilized powder, it is intended strictly for laboratory research; it is not for human or veterinary administration.